Research and analysis

Genetically Modified Organisms: Bavarian Nordic Inc. (12/R44/01)

Details of the consent for Bavarian Nordic Inc. (formerly BN ImmunoTherapeutics Inc.) to release genetically modified organisms.

From:
Department for Environment, Food & Rural Affairs
Published
22 November 2013
Last updated
4 February 2015 — See all updates

Documents

12/R44/01: Consent variation (9 December 2014)

PDF, 64.9 KB, 4 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

12/R44/01: Consent variation (16 November 2013)

Ref: 12/R44/01

PDF, 86 KB, 4 pages

12/R44/01: Consent (10 December 2012)

Ref: 12/R44/01

PDF, 70.6 KB, 4 pages

12/R44/01: Part A1

Ref: 12/R44/01

PDF, 551 KB, 63 pages

12/R44/01: Part A2 to A6

Ref: 12/R44/01

PDF, 1.07 MB, 65 pages

12/R44/01: Part B

Ref: 12/R44/01

PDF, 94.2 KB, 6 pages

Details

Consent documents for Bavarian Nordic Inc. (formerly BN ImmunoTherapeutics Inc.), to release genetically modified organisms for research purposes.

Each consent granted includes:

  • consent letter (confirming consent and outlining any conditions)
  • part A(1): Information required under schedule 1 of the Genetically Modified Organisms (Deliberate Release) regulations 2002.
  • part A(2-6): (If applicable) Details of related previous releases, including any data, results and risks.
  • part B: Information about the release application to be included on the public register

ACRE’s advice

Updates to this page

Published 22 November 2013
Last updated 4 February 2015 + show all updates

  1. Added 12/R44/01: Consent variation (9 December 2014)

  2. First published.

Sign up for emails or print this page

Related content